SOPs for Injectables V 2.0

To define a standardized procedure for cross-verification of in-process control (IPC) data to ensure completeness, correctness, consistency, and integrity of recorded observations in sterile injectable manufacturing.
Click to read the full article.

This SOP defines the systematic approach to reviewing Batch Manufacturing Records (BMR) in sterile injectable manufacturing to ensure completeness, accuracy, and compliance with GMP regulations.
Click to read the full article.

To define the procedure for batch release of sterile injectable products after completion of manufacturing, quality control, and review of necessary documentation, ensuring product quality, safety, and compliance with GMP regulations.
Click to read the full article.

To define the procedure for conducting internal quality audits within the sterile injectable manufacturing facility to assess compliance with cGMP, company standards, and regulatory expectations, and to identify areas of improvement.
Click to read the full article.

To establish a standard procedure for identifying, documenting, investigating, and resolving deviations encountered in processes, systems, or documentation related to sterile injectable manufacturing operations, ensuring consistent product quality and regulatory compliance.
Click to read the full article.

This SOP provides a systematic approach to risk assessment in sterile injectable manufacturing. It ensures potential risks to product quality, patient safety, and regulatory compliance are proactively identified, analyzed, mitigated, and documented using scientific and process-based rationale.
Click to read the full article.

To establish a standardized procedure for qualifying, requalifying, and disqualifying suppliers of raw materials used in the sterile injectable manufacturing process, ensuring regulatory compliance and consistent material quality.
Click to read the full article.

To outline a systematic procedure for the calibration of instruments and equipment used in Quality Assurance (QA) laboratories to ensure consistent performance, data accuracy, and regulatory compliance in sterile injectable manufacturing.
Click to read the full article.

To define a standard procedure for managing, investigating, and closing complaints related to sterile injectable products, ensuring product quality, patient safety, and regulatory compliance.
Click to read the full article.

To establish a standardized procedure for managing changes that may affect the quality, safety, or efficacy of sterile injectable products. This includes changes in facilities, processes, equipment, documents, materials, and utilities, ensuring control and compliance with regulatory and GMP requirements.
Click to read the full article.